UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Trimmed by Aureus Asset Management LLC

Aureus Asset Management LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 81,289 shares of the healthcare conglomerate’s stock after selling 721 shares during the period. UnitedHealth Group accounts for 3.1% of Aureus Asset Management LLC’s portfolio, making the stock its 8th biggest position. Aureus Asset Management LLC’s holdings in UnitedHealth Group were worth $47,528,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in UNH. Bank & Trust Co bought a new stake in UnitedHealth Group in the second quarter worth $58,000. Mather Group LLC. lifted its holdings in shares of UnitedHealth Group by 8.2% during the second quarter. Mather Group LLC. now owns 5,403 shares of the healthcare conglomerate’s stock valued at $2,673,000 after purchasing an additional 408 shares in the last quarter. Kingswood Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 4.5% during the second quarter. Kingswood Wealth Advisors LLC now owns 15,102 shares of the healthcare conglomerate’s stock valued at $7,691,000 after purchasing an additional 646 shares in the last quarter. Astoria Portfolio Advisors LLC. lifted its holdings in shares of UnitedHealth Group by 7.5% during the second quarter. Astoria Portfolio Advisors LLC. now owns 3,351 shares of the healthcare conglomerate’s stock valued at $1,707,000 after purchasing an additional 235 shares in the last quarter. Finally, Somerset Trust Co lifted its holdings in shares of UnitedHealth Group by 1.4% during the second quarter. Somerset Trust Co now owns 6,299 shares of the healthcare conglomerate’s stock valued at $3,208,000 after purchasing an additional 85 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently commented on the company. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald upped their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $618.26.

UnitedHealth Group Stock Performance

NYSE UNH opened at $610.20 on Monday. The stock has a market capitalization of $561.55 billion, a PE ratio of 39.75, a P/E/G ratio of 1.79 and a beta of 0.58. The business has a 50 day simple moving average of $585.43 and a two-hundred day simple moving average of $556.65. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.